A large psilocybin dose briefly improved advanced dementia symptoms in an isolated case study but experts warn of the dangers ...

A woman with Alzheimer's who had barely spoken in years tried psilocybin therapy and began talking again just 19 hours later.

A woman with advanced dementia appeared to regain speech and independence after psilocybin. The findings are intriguing, but ...

Now that psychedelic research has been legitimized, scientists at university labs and biotech start-ups are wondering whether ...

Dementia is a degenerative disease that no known drug can completely stop or reverse, despite decades of tests. Now, a ...

An analysis of the 2024 National Survey on Drug Use and Health (NSDUH) data revealed that 2.8% of participating Americans ...

In a new study, UC Berkeley researchers are investigating whether psilocybin can support healthy aging by boosting plasticity ...

Psilocybin is a naturally occurring psychoactive compound found in mushrooms of the Psilocybe genus. These mushrooms may have ...

One of the first real-world studies of psilocybin therapy suggests meaningful improvements in treatment-resistant depression outside the controlled setting of clinical trials.

A new look at data from a nationally representative survey finds that more than 8 million people, roughly 2.8% of the U.S.

VANCOUVER, British Columbia, June 10, 2026 (GLOBE NEWSWIRE) -- via IBN – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the ...

The woman, who typically speaks in single syllables, showed measurable improvements.